Guru Ownership Trend
Guru Analysis for Actuate Therapeutics, Inc. (ACTU)
Actuate Therapeutics, Inc. (ACTU), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $65,811.89.
Top institutional holders include Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $153,587.29 net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 370.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Actuate Therapeutics, Inc. (ACTU)
Major holders include Cliff Asness ($195,064). According to the latest reported data, 1 tracked investment managers collectively hold approximately 127,493 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $153,587.29, with 1 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in ACTU during the most recent reporting period.
Yes, 0 managers opened new positions in ACTU, and 1 increased their existing holdings. The total reported buy value was $153,587.29.